Responses
Regular and Young Investigator Award Abstracts
Clinical Trial Completed
628 Circulatory plasma proteomic biomarkers combined with high-throughput proteomic screen of patient-derived organotypic tumor spheroids predict responses to immunotherapy in melanoma patients
Compose a Response to This Article
Other responses
No responses have been published for this article.
